124 related articles for article (PubMed ID: 335966)
1. Rapid microdilution-colorimetric assay for yeast susceptibility to fluorocytosine.
Fisher BD; Armstrong D
Antimicrob Agents Chemother; 1977 Nov; 12(5):614-7. PubMed ID: 335966
[TBL] [Abstract][Full Text] [Related]
2. Assay for yeast susceptibility to 5-fluorocytosine and amphotericin B in a frozen microtiter system.
Ellis NS; Bartlett MS; Smith JW
Am J Clin Pathol; 1979 Aug; 72(2):194-8. PubMed ID: 382827
[TBL] [Abstract][Full Text] [Related]
3. Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.
Mazens MF; Andrews GP; Bartlett RC
Antimicrob Agents Chemother; 1979 Mar; 15(3):475-7. PubMed ID: 464576
[TBL] [Abstract][Full Text] [Related]
4. Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
Beggs WH; Sarosi GA
Antimicrob Agents Chemother; 1982 Feb; 21(2):355-7. PubMed ID: 6280603
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a novel colorimetric broth microdilution method for antifungal susceptibility testing of yeast isolates.
Pfaller MA; Barry AL
J Clin Microbiol; 1994 Aug; 32(8):1992-6. PubMed ID: 7989555
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Morace G; Manzara S; Dettori G
Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
[TBL] [Abstract][Full Text] [Related]
7. Antifungal activity of 5-fluorocytosine as measured by disk diffusion susceptibility testing.
Utz CJ; Shadomy S
J Infect Dis; 1977 Jun; 135(6):970-4. PubMed ID: 325150
[TBL] [Abstract][Full Text] [Related]
8. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
To WK; Fothergill AW; Rinaldi MG
J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
[TBL] [Abstract][Full Text] [Related]
9. In vitro studies with combinations of 5-fluorocytosine and amphotericin B.
Shadomy S; Wagner G; Espinel-Ingroff E; Davis BA
Antimicrob Agents Chemother; 1975 Aug; 8(2):117-21. PubMed ID: 1101814
[TBL] [Abstract][Full Text] [Related]
10. Morphological changes in yeasts as a result of the action of 5-fluorocytosine.
Arai T; Mikami Y; Yokoyama K; Kawata T; Masuda K
Antimicrob Agents Chemother; 1977 Aug; 12(2):255-60. PubMed ID: 332075
[TBL] [Abstract][Full Text] [Related]
11. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility to 5-fluorocytosine and nystatin of common clinical yeast isolates.
Nobre G; Sobral T; Ferreira AF
Mycopathologia; 1981 Jan; 73(1):39-41. PubMed ID: 7012631
[TBL] [Abstract][Full Text] [Related]
13. Combined action of amphotericin B and 5-fluorocytosine on pathogenic yeasts susceptible to either drug alone.
Beggs WH; Andrews FA; Sarosi GA
Chemotherapy; 1981; 27(4):247-51. PubMed ID: 7195793
[TBL] [Abstract][Full Text] [Related]
14. Phenotypes of resistance to fluorophyrimidines and the occurence of 5-fluorocytosine resistant mutants in Candida and Torulopsis yeasts.
Pawlik B; Barylak J
Mykosen; 1978 Nov; 21(11):377-81. PubMed ID: 570245
[No Abstract] [Full Text] [Related]
15. Synergism of amphotericin B and 5-fluorocytosine for candida species.
Montgomerie JZ; Edwards JE; Guze LB
J Infect Dis; 1975 Jul; 132(1):82-6. PubMed ID: 1097545
[TBL] [Abstract][Full Text] [Related]
16. [Multisite evaluation of a colorimetric broth microdilution antifungal susceptibility testing].
Yamane N; Igari J
Rinsho Byori; 1997 Feb; 45(2):190-9. PubMed ID: 9121005
[TBL] [Abstract][Full Text] [Related]
17. Radiometric method for determining the susceptibility of yeasts to 5-fluorocytosine.
Hopfer RL; Mills K; Gröschel D
Antimicrob Agents Chemother; 1979 Feb; 15(2):313-4. PubMed ID: 426519
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
Ahearn DG; McGlohn MS
J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
Pfaller MA; Barry AL
Mycopathologia; 1995; 130(1):3-9. PubMed ID: 7666925
[TBL] [Abstract][Full Text] [Related]
20. [Synergic effect of 5-fluorocytosine and imidazole derivatives against yeast strains resistant to 5-fluorocytosine].
Mary C; Goudard M; Blancard A; Quilici M; Regli P
Ann Biol Clin (Paris); 1989; 47(9):546-9. PubMed ID: 2558599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
